nodes	percent_of_prediction	percent_of_DWPC	metapath
Phylloquinone—GGCX—cardial valve—coronary artery disease	0.208	0.839	CbGeAlD
Phylloquinone—GGCX—Gamma-carboxylation, transport, and amino-terminal cleavage of proteins—VKORC1—coronary artery disease	0.0534	0.136	CbGpPWpGaD
Phylloquinone—GGCX—PTM: gamma carboxylation, hypusine formation and arylsulfatase activation—VKORC1—coronary artery disease	0.0253	0.0644	CbGpPWpGaD
Phylloquinone—GGCX—Gamma-carboxylation of protein precursors—F7—coronary artery disease	0.0197	0.0502	CbGpPWpGaD
Phylloquinone—GGCX—Gamma-carboxylation, transport, and amino-terminal cleavage of proteins—F7—coronary artery disease	0.0168	0.0428	CbGpPWpGaD
Phylloquinone—GGCX—heart—coronary artery disease	0.0115	0.0464	CbGeAlD
Phylloquinone—Vitamin E—PPP2CA—coronary artery disease	0.0113	0.371	CrCbGaD
Phylloquinone—BGLAP—cardiovascular system—coronary artery disease	0.0111	0.0448	CbGeAlD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—CKM—coronary artery disease	0.0102	0.0259	CbGpPWpGaD
Phylloquinone—GGCX—Gamma-carboxylation of protein precursors—F2—coronary artery disease	0.00998	0.0254	CbGpPWpGaD
Phylloquinone—BGLAP—Osteoblast Signaling—ITGAV—coronary artery disease	0.00951	0.0242	CbGpPWpGaD
Phylloquinone—BGLAP—blood—coronary artery disease	0.00879	0.0354	CbGeAlD
Phylloquinone—GGCX—blood—coronary artery disease	0.00858	0.0346	CbGeAlD
Phylloquinone—GGCX—Gamma-carboxylation, transport, and amino-terminal cleavage of proteins—F2—coronary artery disease	0.0085	0.0216	CbGpPWpGaD
Phylloquinone—GGCX—PTM: gamma carboxylation, hypusine formation and arylsulfatase activation—F7—coronary artery disease	0.00796	0.0203	CbGpPWpGaD
Phylloquinone—BGLAP—Osteoblast Signaling—ITGB3—coronary artery disease	0.00749	0.0191	CbGpPWpGaD
Phylloquinone—Swelling—Tirofiban—coronary artery disease	0.00735	0.0224	CcSEcCtD
Phylloquinone—Vitamin E—GCLC—coronary artery disease	0.00699	0.229	CrCbGaD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—THBD—coronary artery disease	0.00691	0.0176	CbGpPWpGaD
Phylloquinone—BGLAP—Notch-mediated HES/HEY network—GHR—coronary artery disease	0.00681	0.0173	CbGpPWpGaD
Phylloquinone—BGLAP—Notch-mediated HES/HEY network—GATA4—coronary artery disease	0.00621	0.0158	CbGpPWpGaD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—DCN—coronary artery disease	0.00616	0.0157	CbGpPWpGaD
Phylloquinone—Vitamin E—HMOX1—coronary artery disease	0.00579	0.19	CrCbGaD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—CEBPD—coronary artery disease	0.00544	0.0138	CbGpPWpGaD
Phylloquinone—Sweating—Tirofiban—coronary artery disease	0.00479	0.0146	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—JUNB—coronary artery disease	0.0047	0.012	CbGpPWpGaD
Phylloquinone—BGLAP—FGF signaling pathway—CDH2—coronary artery disease	0.00455	0.0116	CbGpPWpGaD
Phylloquinone—BGLAP—Notch-mediated HES/HEY network—CAMK2D—coronary artery disease	0.00452	0.0115	CbGpPWpGaD
Phylloquinone—Hyperbilirubinaemia—Clopidogrel—coronary artery disease	0.00446	0.0136	CcSEcCtD
Phylloquinone—Necrosis—Niacin—coronary artery disease	0.0044	0.0134	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAUR—coronary artery disease	0.00432	0.011	CbGpPWpGaD
Phylloquinone—Hyperbilirubinaemia—Eplerenone—coronary artery disease	0.00425	0.0129	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—GJA1—coronary artery disease	0.00419	0.0107	CbGpPWpGaD
Phylloquinone—GGCX—Post-translational protein modification—VKORC1—coronary artery disease	0.00414	0.0105	CbGpPWpGaD
Phylloquinone—Inflammation—Ezetimibe—coronary artery disease	0.00407	0.0124	CcSEcCtD
Phylloquinone—GGCX—PTM: gamma carboxylation, hypusine formation and arylsulfatase activation—F2—coronary artery disease	0.00403	0.0102	CbGpPWpGaD
Phylloquinone—Necrosis—Captopril—coronary artery disease	0.00402	0.0122	CcSEcCtD
Phylloquinone—Vitamin E—SOD1—coronary artery disease	0.00401	0.132	CrCbGaD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—HMOX1—coronary artery disease	0.0039	0.00991	CbGpPWpGaD
Phylloquinone—Hyperbilirubinaemia—Olmesartan—coronary artery disease	0.00389	0.0118	CcSEcCtD
Phylloquinone—Inflammation—Simvastatin—coronary artery disease	0.00388	0.0118	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—NR4A1—coronary artery disease	0.0038	0.00968	CbGpPWpGaD
Phylloquinone—Hyperbilirubinaemia—Niacin—coronary artery disease	0.0038	0.0116	CcSEcCtD
Phylloquinone—BGLAP—FGF signaling pathway—DUSP6—coronary artery disease	0.00373	0.00949	CbGpPWpGaD
Phylloquinone—Injection site pain—Furosemide—coronary artery disease	0.00365	0.0111	CcSEcCtD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—SOCS3—coronary artery disease	0.00348	0.00885	CbGpPWpGaD
Phylloquinone—Phlebitis—Fenofibrate—coronary artery disease	0.00347	0.0106	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—SELE—coronary artery disease	0.00347	0.00882	CbGpPWpGaD
Phylloquinone—Sweating—Penbutolol—coronary artery disease	0.00339	0.0103	CcSEcCtD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—TGFB2—coronary artery disease	0.00336	0.00855	CbGpPWpGaD
Phylloquinone—BGLAP—FGF signaling pathway—PLAUR—coronary artery disease	0.00319	0.00812	CbGpPWpGaD
Phylloquinone—Anaphylactic shock—Tirofiban—coronary artery disease	0.00319	0.0097	CcSEcCtD
Phylloquinone—GGCX—Post-translational protein modification—ADAMTS7—coronary artery disease	0.00314	0.00799	CbGpPWpGaD
Phylloquinone—Swelling—Simvastatin—coronary artery disease	0.0031	0.00943	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP1—coronary artery disease	0.00309	0.00785	CbGpPWpGaD
Phylloquinone—Hyperhidrosis—Tirofiban—coronary artery disease	0.00308	0.00938	CcSEcCtD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—RPS6KB1—coronary artery disease	0.00307	0.00782	CbGpPWpGaD
Phylloquinone—Anaphylactoid reaction—Clopidogrel—coronary artery disease	0.00304	0.00925	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAU—coronary artery disease	0.00303	0.00771	CbGpPWpGaD
Phylloquinone—Swelling—Valsartan—coronary artery disease	0.00293	0.0089	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—IRF1—coronary artery disease	0.00288	0.00734	CbGpPWpGaD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—BIRC5—coronary artery disease	0.00287	0.00731	CbGpPWpGaD
Phylloquinone—Pain—Tirofiban—coronary artery disease	0.00272	0.00829	CcSEcCtD
Phylloquinone—Swelling—Enalapril—coronary artery disease	0.00271	0.00825	CcSEcCtD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—CCND2—coronary artery disease	0.00269	0.00684	CbGpPWpGaD
Phylloquinone—BGLAP—FGF signaling pathway—HGF—coronary artery disease	0.00268	0.00683	CbGpPWpGaD
Phylloquinone—BGLAP—FGF signaling pathway—FGF1—coronary artery disease	0.00265	0.00675	CbGpPWpGaD
Phylloquinone—BGLAP—Notch-mediated HES/HEY network—HIF1A—coronary artery disease	0.00253	0.00643	CbGpPWpGaD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—coronary artery disease	0.00251	0.00639	CbGpPWpGaD
Phylloquinone—Sweating—Acetylsalicylic acid—coronary artery disease	0.00247	0.00753	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Enalapril—coronary artery disease	0.00247	0.00752	CcSEcCtD
Phylloquinone—Swelling—Furosemide—coronary artery disease	0.00245	0.00746	CcSEcCtD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—IL6ST—coronary artery disease	0.00244	0.00621	CbGpPWpGaD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—ICAM1—coronary artery disease	0.00244	0.00621	CbGpPWpGaD
Phylloquinone—BGLAP—Notch-mediated HES/HEY network—KDR—coronary artery disease	0.00242	0.00615	CbGpPWpGaD
Phylloquinone—Immune system disorder—Ticagrelor—coronary artery disease	0.00239	0.00728	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—coronary artery disease	0.00239	0.00608	CbGpPWpGaD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—SIRT1—coronary artery disease	0.00238	0.00606	CbGpPWpGaD
Phylloquinone—Anaphylactoid reaction—Captopril—coronary artery disease	0.00237	0.00721	CcSEcCtD
Phylloquinone—Swelling—Losartan—coronary artery disease	0.00237	0.0072	CcSEcCtD
Phylloquinone—Hypersensitivity—Tirofiban—coronary artery disease	0.00235	0.00715	CcSEcCtD
Phylloquinone—Vitamin E—GSTP1—coronary artery disease	0.00235	0.0771	CrCbGaD
Phylloquinone—Anaphylactoid reaction—Perindopril—coronary artery disease	0.0023	0.007	CcSEcCtD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—CSF2—coronary artery disease	0.00226	0.00575	CbGpPWpGaD
Phylloquinone—BGLAP—FGF signaling pathway—PLAU—coronary artery disease	0.00224	0.0057	CbGpPWpGaD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—coronary artery disease	0.00224	0.00569	CbGpPWpGaD
Phylloquinone—Anaphylactoid reaction—Furosemide—coronary artery disease	0.00223	0.0068	CcSEcCtD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—CREB1—coronary artery disease	0.00223	0.00568	CbGpPWpGaD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—MEF2C—coronary artery disease	0.00222	0.00565	CbGpPWpGaD
Phylloquinone—Sweating—Fenofibrate—coronary artery disease	0.00221	0.00673	CcSEcCtD
Phylloquinone—Hyperhidrosis—Penbutolol—coronary artery disease	0.00218	0.00665	CcSEcCtD
Phylloquinone—Flushing—Acetylsalicylic acid—coronary artery disease	0.00215	0.00655	CcSEcCtD
Phylloquinone—BGLAP—FGF signaling pathway—MAPK14—coronary artery disease	0.00215	0.00547	CbGpPWpGaD
Phylloquinone—Dizziness—Tirofiban—coronary artery disease	0.00211	0.00641	CcSEcCtD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—PPP2CA—coronary artery disease	0.0021	0.00535	CbGpPWpGaD
Phylloquinone—Sweating increased—Pravastatin—coronary artery disease	0.00208	0.00633	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—STAT5A—coronary artery disease	0.00204	0.0052	CbGpPWpGaD
Phylloquinone—Dyspnoea—Penbutolol—coronary artery disease	0.00201	0.00613	CcSEcCtD
Phylloquinone—Sweating increased—Enalapril—coronary artery disease	0.00201	0.00612	CcSEcCtD
Phylloquinone—Hypersensitivity—Pitavastatin—coronary artery disease	0.002	0.0061	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CXCL8—coronary artery disease	0.00198	0.00505	CbGpPWpGaD
Phylloquinone—Sweating increased—Telmisartan—coronary artery disease	0.00198	0.00604	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—VKORC1—coronary artery disease	0.00197	0.005	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—PAPPA—coronary artery disease	0.00197	0.005	CbGpPWpGaD
Phylloquinone—Pain—Penbutolol—coronary artery disease	0.00193	0.00588	CcSEcCtD
Phylloquinone—Anaphylactic shock—Gemfibrozil—coronary artery disease	0.00193	0.00587	CcSEcCtD
Phylloquinone—GGCX—Post-translational protein modification—CANX—coronary artery disease	0.0019	0.00484	CbGpPWpGaD
Phylloquinone—GGCX—Post-translational protein modification—ADAMTS1—coronary artery disease	0.0019	0.00484	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—CSF2—coronary artery disease	0.0019	0.00483	CbGpPWpGaD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—JAK2—coronary artery disease	0.00189	0.00482	CbGpPWpGaD
Phylloquinone—Flushing—Lovastatin—coronary artery disease	0.00188	0.00571	CcSEcCtD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—BCL2—coronary artery disease	0.00188	0.00477	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—BAX—coronary artery disease	0.00187	0.00476	CbGpPWpGaD
Phylloquinone—Sweating—Niacin—coronary artery disease	0.00185	0.00564	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Ramipril—coronary artery disease	0.00185	0.00563	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—coronary artery disease	0.00185	0.0047	CbGpPWpGaD
Phylloquinone—Flushing—Ezetimibe—coronary artery disease	0.00184	0.0056	CcSEcCtD
Phylloquinone—Immune system disorder—Clopidogrel—coronary artery disease	0.00184	0.00559	CcSEcCtD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—MAPK14—coronary artery disease	0.00183	0.00465	CbGpPWpGaD
Phylloquinone—Erythema—Fenofibrate—coronary artery disease	0.0018	0.00548	CcSEcCtD
Phylloquinone—Flushing—Eplerenone—coronary artery disease	0.0018	0.00548	CcSEcCtD
Phylloquinone—Dizziness—Pitavastatin—coronary artery disease	0.0018	0.00548	CcSEcCtD
Phylloquinone—BGLAP—Notch-mediated HES/HEY network—JAK2—coronary artery disease	0.0018	0.00457	CbGpPWpGaD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—coronary artery disease	0.00179	0.00457	CbGpPWpGaD
Phylloquinone—Immune system disorder—Ezetimibe—coronary artery disease	0.00179	0.00545	CcSEcCtD
Phylloquinone—Sweating—Trandolapril—coronary artery disease	0.00177	0.0054	CcSEcCtD
Phylloquinone—Hypotension—Ticagrelor—coronary artery disease	0.00176	0.00535	CcSEcCtD
Phylloquinone—Flushing—Simvastatin—coronary artery disease	0.00175	0.00534	CcSEcCtD
Phylloquinone—Erythema—Ezetimibe—coronary artery disease	0.00173	0.00525	CcSEcCtD
Phylloquinone—Dyspnoea—Ticagrelor—coronary artery disease	0.00168	0.00511	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Lisinopril—coronary artery disease	0.00168	0.0051	CcSEcCtD
Phylloquinone—Pain—Gemfibrozil—coronary artery disease	0.00165	0.00502	CcSEcCtD
Phylloquinone—Anaphylactic shock—Acetylsalicylic acid—coronary artery disease	0.00165	0.00501	CcSEcCtD
Phylloquinone—Erythema—Simvastatin—coronary artery disease	0.00165	0.00501	CcSEcCtD
Phylloquinone—Sweating—Perindopril—coronary artery disease	0.00164	0.005	CcSEcCtD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—PPARG—coronary artery disease	0.00164	0.00417	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—MMP1—coronary artery disease	0.00163	0.00415	CbGpPWpGaD
Phylloquinone—Immune system disorder—Valsartan—coronary artery disease	0.00161	0.00491	CcSEcCtD
Phylloquinone—Flushing—Niacin—coronary artery disease	0.00161	0.0049	CcSEcCtD
Phylloquinone—Sweating—Furosemide—coronary artery disease	0.0016	0.00486	CcSEcCtD
Phylloquinone—Hyperhidrosis—Acetylsalicylic acid—coronary artery disease	0.00159	0.00484	CcSEcCtD
Phylloquinone—Flushing—Pravastatin—coronary artery disease	0.00159	0.00483	CcSEcCtD
Phylloquinone—Sweating—Losartan—coronary artery disease	0.00154	0.00469	CcSEcCtD
Phylloquinone—Flushing—Trandolapril—coronary artery disease	0.00154	0.00469	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—MAPK14—coronary artery disease	0.00154	0.00391	CbGpPWpGaD
Phylloquinone—Flushing—Enalapril—coronary artery disease	0.00153	0.00467	CcSEcCtD
Phylloquinone—Flushing—Telmisartan—coronary artery disease	0.00151	0.00461	CcSEcCtD
Phylloquinone—Erythema—Niacin—coronary artery disease	0.00151	0.0046	CcSEcCtD
Phylloquinone—Sweating increased—Ramipril—coronary artery disease	0.00151	0.00459	CcSEcCtD
Phylloquinone—Immune system disorder—Trandolapril—coronary artery disease	0.0015	0.00456	CcSEcCtD
Phylloquinone—Dizziness—Penbutolol—coronary artery disease	0.00149	0.00455	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—ADAMTS7—coronary artery disease	0.00149	0.00379	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—ICAM1—coronary artery disease	0.00148	0.00378	CbGpPWpGaD
Phylloquinone—Immune system disorder—Telmisartan—coronary artery disease	0.00147	0.00448	CcSEcCtD
Phylloquinone—Flushing—Captopril—coronary artery disease	0.00147	0.00448	CcSEcCtD
Phylloquinone—Dyspnoea—Acetylsalicylic acid—coronary artery disease	0.00147	0.00447	CcSEcCtD
Phylloquinone—Pain—Rosuvastatin—coronary artery disease	0.00145	0.00441	CcSEcCtD
Phylloquinone—Anaphylactic shock—Clopidogrel—coronary artery disease	0.00145	0.0044	CcSEcCtD
Phylloquinone—Erythema—Enalapril—coronary artery disease	0.00144	0.00438	CcSEcCtD
Phylloquinone—Anaphylactic shock—Lovastatin—coronary artery disease	0.00144	0.00437	CcSEcCtD
Phylloquinone—Flushing—Perindopril—coronary artery disease	0.00143	0.00435	CcSEcCtD
Phylloquinone—Hyperhidrosis—Fenofibrate—coronary artery disease	0.00142	0.00433	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—KLK1—coronary artery disease	0.00142	0.00362	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—HSPA9—coronary artery disease	0.00142	0.00362	CbGpPWpGaD
Phylloquinone—Erythema—Telmisartan—coronary artery disease	0.00142	0.00432	CcSEcCtD
Phylloquinone—Anaphylactic shock—Ezetimibe—coronary artery disease	0.00141	0.00429	CcSEcCtD
Phylloquinone—Hypersensitivity—Ticagrelor—coronary artery disease	0.00139	0.00422	CcSEcCtD
Phylloquinone—Hypotension—Fenofibrate—coronary artery disease	0.00137	0.00418	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—GSK3B—coronary artery disease	0.00137	0.00348	CbGpPWpGaD
Phylloquinone—Sweating increased—Lisinopril—coronary artery disease	0.00137	0.00416	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—EIF2AK3—coronary artery disease	0.00136	0.00347	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—POMC—coronary artery disease	0.00136	0.00345	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—CREB1—coronary artery disease	0.00136	0.00345	CbGpPWpGaD
Phylloquinone—Immune system disorder—Furosemide—coronary artery disease	0.00135	0.00411	CcSEcCtD
Phylloquinone—Hypotension—Clopidogrel—coronary artery disease	0.00135	0.00411	CcSEcCtD
Phylloquinone—Anaphylactic shock—Simvastatin—coronary artery disease	0.00134	0.00409	CcSEcCtD
Phylloquinone—Erythema—Perindopril—coronary artery disease	0.00134	0.00408	CcSEcCtD
Phylloquinone—Flushing—Losartan—coronary artery disease	0.00134	0.00408	CcSEcCtD
Phylloquinone—Hyperhidrosis—Eplerenone—coronary artery disease	0.00133	0.00406	CcSEcCtD
Phylloquinone—BGLAP—FGF signaling pathway—MMP9—coronary artery disease	0.00133	0.00338	CbGpPWpGaD
Phylloquinone—Sweating—Ramipril—coronary artery disease	0.00132	0.00402	CcSEcCtD
Phylloquinone—Dyspnoea—Fenofibrate—coronary artery disease	0.00131	0.00399	CcSEcCtD
Phylloquinone—GGCX—Post-translational protein modification—F7—coronary artery disease	0.0013	0.00332	CbGpPWpGaD
Phylloquinone—Erythema—Furosemide—coronary artery disease	0.0013	0.00397	CcSEcCtD
Phylloquinone—Sweating—Timolol—coronary artery disease	0.00129	0.00393	CcSEcCtD
Phylloquinone—Dyspnoea—Clopidogrel—coronary artery disease	0.00129	0.00392	CcSEcCtD
Phylloquinone—Hypotension—Eplerenone—coronary artery disease	0.00129	0.00392	CcSEcCtD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—TGFB1—coronary artery disease	0.00129	0.00328	CbGpPWpGaD
Phylloquinone—Dyspnoea—Lovastatin—coronary artery disease	0.00128	0.0039	CcSEcCtD
Phylloquinone—Dizziness—Gemfibrozil—coronary artery disease	0.00127	0.00388	CcSEcCtD
Phylloquinone—Anaphylactic shock—Valsartan—coronary artery disease	0.00127	0.00386	CcSEcCtD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—MAPK1—coronary artery disease	0.00126	0.00321	CbGpPWpGaD
Phylloquinone—Anaphylactic shock—Olmesartan—coronary artery disease	0.00126	0.00384	CcSEcCtD
Phylloquinone—Pain—Fenofibrate—coronary artery disease	0.00126	0.00383	CcSEcCtD
Phylloquinone—Erythema—Losartan—coronary artery disease	0.00126	0.00383	CcSEcCtD
Phylloquinone—Dyspnoea—Ezetimibe—coronary artery disease	0.00126	0.00382	CcSEcCtD
Phylloquinone—Hypersensitivity—Rosuvastatin—coronary artery disease	0.00125	0.0038	CcSEcCtD
Phylloquinone—Dizziness—Ticagrelor—coronary artery disease	0.00124	0.00379	CcSEcCtD
Phylloquinone—GGCX—Post-translational protein modification—THBS1—coronary artery disease	0.00124	0.00316	CbGpPWpGaD
Phylloquinone—Pain—Clopidogrel—coronary artery disease	0.00124	0.00376	CcSEcCtD
Phylloquinone—Anaphylactic shock—Niacin—coronary artery disease	0.00123	0.00375	CcSEcCtD
Phylloquinone—Dyspnoea—Eplerenone—coronary artery disease	0.00123	0.00374	CcSEcCtD
Phylloquinone—Pain—Lovastatin—coronary artery disease	0.00123	0.00374	CcSEcCtD
Phylloquinone—Hyperhidrosis—Olmesartan—coronary artery disease	0.00122	0.00371	CcSEcCtD
Phylloquinone—Anaphylactic shock—Pravastatin—coronary artery disease	0.00121	0.0037	CcSEcCtD
Phylloquinone—Hypersensitivity—Acetylsalicylic acid—coronary artery disease	0.00121	0.00369	CcSEcCtD
Phylloquinone—Pain—Ezetimibe—coronary artery disease	0.0012	0.00367	CcSEcCtD
Phylloquinone—Sweating—Lisinopril—coronary artery disease	0.0012	0.00365	CcSEcCtD
Phylloquinone—Dyspnoea—Simvastatin—coronary artery disease	0.0012	0.00365	CcSEcCtD
Phylloquinone—Hyperhidrosis—Niacin—coronary artery disease	0.00119	0.00363	CcSEcCtD
Phylloquinone—Hypotension—Valsartan—coronary artery disease	0.00119	0.00361	CcSEcCtD
Phylloquinone—GGCX—Post-translational protein modification—CALR—coronary artery disease	0.00118	0.00301	CbGpPWpGaD
Phylloquinone—Hypotension—Olmesartan—coronary artery disease	0.00118	0.00359	CcSEcCtD
Phylloquinone—Pain—Eplerenone—coronary artery disease	0.00118	0.00359	CcSEcCtD
Phylloquinone—Anaphylactic shock—Enalapril—coronary artery disease	0.00117	0.00358	CcSEcCtD
Phylloquinone—Hyperhidrosis—Pravastatin—coronary artery disease	0.00117	0.00357	CcSEcCtD
Phylloquinone—BGLAP—Regulation of retinoblastoma protein—CCND1—coronary artery disease	0.00116	0.00296	CbGpPWpGaD
Phylloquinone—Anaphylactic shock—Telmisartan—coronary artery disease	0.00116	0.00353	CcSEcCtD
Phylloquinone—Hypotension—Niacin—coronary artery disease	0.00115	0.00351	CcSEcCtD
Phylloquinone—Flushing—Ramipril—coronary artery disease	0.00115	0.0035	CcSEcCtD
Phylloquinone—Pain—Simvastatin—coronary artery disease	0.00115	0.0035	CcSEcCtD
Phylloquinone—Hyperhidrosis—Trandolapril—coronary artery disease	0.00114	0.00347	CcSEcCtD
Phylloquinone—Hyperhidrosis—Enalapril—coronary artery disease	0.00114	0.00346	CcSEcCtD
Phylloquinone—Dyspnoea—Valsartan—coronary artery disease	0.00113	0.00344	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—ACE2—coronary artery disease	0.00113	0.00287	CbGpPWpGaD
Phylloquinone—Anaphylactic shock—Captopril—coronary artery disease	0.00113	0.00343	CcSEcCtD
Phylloquinone—Dizziness—Rosuvastatin—coronary artery disease	0.00112	0.00341	CcSEcCtD
Phylloquinone—Hyperhidrosis—Telmisartan—coronary artery disease	0.00112	0.00341	CcSEcCtD
Phylloquinone—Immune system disorder—Ramipril—coronary artery disease	0.00112	0.0034	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—coronary artery disease	0.00111	0.00284	CbGpPWpGaD
Phylloquinone—Hypotension—Trandolapril—coronary artery disease	0.0011	0.00335	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—TUBA1A—coronary artery disease	0.0011	0.0028	CbGpPWpGaD
Phylloquinone—Dyspnoea—Niacin—coronary artery disease	0.0011	0.00335	CcSEcCtD
Phylloquinone—Hypotension—Enalapril—coronary artery disease	0.0011	0.00334	CcSEcCtD
Phylloquinone—Anaphylactic shock—Perindopril—coronary artery disease	0.00109	0.00333	CcSEcCtD
Phylloquinone—Immune system disorder—Timolol—coronary artery disease	0.00109	0.00333	CcSEcCtD
Phylloquinone—Dizziness—Acetylsalicylic acid—coronary artery disease	0.00109	0.00331	CcSEcCtD
Phylloquinone—Hypersensitivity—Fenofibrate—coronary artery disease	0.00108	0.0033	CcSEcCtD
Phylloquinone—Dyspnoea—Pravastatin—coronary artery disease	0.00108	0.0033	CcSEcCtD
Phylloquinone—Hypotension—Telmisartan—coronary artery disease	0.00108	0.0033	CcSEcCtD
Phylloquinone—Pain—Olmesartan—coronary artery disease	0.00108	0.00329	CcSEcCtD
Phylloquinone—Erythema—Ramipril—coronary artery disease	0.00108	0.00328	CcSEcCtD
Phylloquinone—BGLAP—FGF signaling pathway—MAPK1—coronary artery disease	0.00107	0.00273	CbGpPWpGaD
Phylloquinone—Hypersensitivity—Clopidogrel—coronary artery disease	0.00106	0.00324	CcSEcCtD
Phylloquinone—Anaphylactic shock—Furosemide—coronary artery disease	0.00106	0.00324	CcSEcCtD
Phylloquinone—Hypersensitivity—Lovastatin—coronary artery disease	0.00106	0.00322	CcSEcCtD
Phylloquinone—Hyperhidrosis—Perindopril—coronary artery disease	0.00106	0.00322	CcSEcCtD
Phylloquinone—Pain—Niacin—coronary artery disease	0.00105	0.00321	CcSEcCtD
Phylloquinone—Erythema—Timolol—coronary artery disease	0.00105	0.00321	CcSEcCtD
Phylloquinone—Hypotension—Captopril—coronary artery disease	0.00105	0.0032	CcSEcCtD
Phylloquinone—Dyspnoea—Trandolapril—coronary artery disease	0.00105	0.0032	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—CXCL8—coronary artery disease	0.00105	0.00267	CbGpPWpGaD
Phylloquinone—Dyspnoea—Enalapril—coronary artery disease	0.00105	0.00319	CcSEcCtD
Phylloquinone—Flushing—Lisinopril—coronary artery disease	0.00104	0.00317	CcSEcCtD
Phylloquinone—Pain—Pravastatin—coronary artery disease	0.00104	0.00316	CcSEcCtD
Phylloquinone—Hypersensitivity—Ezetimibe—coronary artery disease	0.00104	0.00316	CcSEcCtD
Phylloquinone—Dyspnoea—Telmisartan—coronary artery disease	0.00103	0.00314	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—KLF4—coronary artery disease	0.00103	0.00263	CbGpPWpGaD
Phylloquinone—Hyperhidrosis—Furosemide—coronary artery disease	0.00103	0.00313	CcSEcCtD
Phylloquinone—Anaphylactic shock—Losartan—coronary artery disease	0.00103	0.00312	CcSEcCtD
Phylloquinone—Hypotension—Perindopril—coronary artery disease	0.00102	0.00311	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—RPL17—coronary artery disease	0.00101	0.00258	CbGpPWpGaD
Phylloquinone—GGCX—Post-translational protein modification—PLAUR—coronary artery disease	0.00101	0.00257	CbGpPWpGaD
Phylloquinone—Dyspnoea—Captopril—coronary artery disease	0.001	0.00306	CcSEcCtD
Phylloquinone—Hypotension—Furosemide—coronary artery disease	0.000993	0.00302	CcSEcCtD
Phylloquinone—Hyperhidrosis—Losartan—coronary artery disease	0.000992	0.00302	CcSEcCtD
Phylloquinone—Pain—Telmisartan—coronary artery disease	0.000991	0.00302	CcSEcCtD
Phylloquinone—Hypersensitivity—Simvastatin—coronary artery disease	0.000989	0.00301	CcSEcCtD
Phylloquinone—Erythema—Lisinopril—coronary artery disease	0.000977	0.00298	CcSEcCtD
Phylloquinone—Dyspnoea—Perindopril—coronary artery disease	0.000975	0.00297	CcSEcCtD
Phylloquinone—Dizziness—Fenofibrate—coronary artery disease	0.000972	0.00296	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—HSP90B1—coronary artery disease	0.00096	0.00244	CbGpPWpGaD
Phylloquinone—Hypotension—Losartan—coronary artery disease	0.000958	0.00292	CcSEcCtD
Phylloquinone—Dizziness—Clopidogrel—coronary artery disease	0.000956	0.00291	CcSEcCtD
Phylloquinone—Dizziness—Lovastatin—coronary artery disease	0.000949	0.00289	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—PLA2G7—coronary artery disease	0.000944	0.0024	CbGpPWpGaD
Phylloquinone—Pain—Perindopril—coronary artery disease	0.000935	0.00285	CcSEcCtD
Phylloquinone—Hypersensitivity—Valsartan—coronary artery disease	0.000934	0.00284	CcSEcCtD
Phylloquinone—Dizziness—Ezetimibe—coronary artery disease	0.000931	0.00284	CcSEcCtD
Phylloquinone—BGLAP—FGF signaling pathway—PIK3CA—coronary artery disease	0.00093	0.00237	CbGpPWpGaD
Phylloquinone—Dyspnoea—Losartan—coronary artery disease	0.000914	0.00278	CcSEcCtD
Phylloquinone—Dizziness—Eplerenone—coronary artery disease	0.000912	0.00277	CcSEcCtD
Phylloquinone—Pain—Furosemide—coronary artery disease	0.000909	0.00277	CcSEcCtD
Phylloquinone—Hypersensitivity—Niacin—coronary artery disease	0.000909	0.00277	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—CANX—coronary artery disease	0.000902	0.0023	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—ADAMTS1—coronary artery disease	0.000902	0.0023	CbGpPWpGaD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—AKT1—coronary artery disease	0.000895	0.00228	CbGpPWpGaD
Phylloquinone—Hypersensitivity—Pravastatin—coronary artery disease	0.000895	0.00272	CcSEcCtD
Phylloquinone—Dizziness—Simvastatin—coronary artery disease	0.000888	0.0027	CcSEcCtD
Phylloquinone—Anaphylactic shock—Ramipril—coronary artery disease	0.00088	0.00268	CcSEcCtD
Phylloquinone—Pain—Losartan—coronary artery disease	0.000877	0.00267	CcSEcCtD
Phylloquinone—Hypersensitivity—Trandolapril—coronary artery disease	0.000869	0.00264	CcSEcCtD
Phylloquinone—Hypersensitivity—Enalapril—coronary artery disease	0.000865	0.00263	CcSEcCtD
Phylloquinone—Anaphylactic shock—Timolol—coronary artery disease	0.00086	0.00262	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—REN—coronary artery disease	0.000855	0.00218	CbGpPWpGaD
Phylloquinone—Hypersensitivity—Telmisartan—coronary artery disease	0.000853	0.0026	CcSEcCtD
Phylloquinone—Hyperhidrosis—Ramipril—coronary artery disease	0.00085	0.00259	CcSEcCtD
Phylloquinone—Dizziness—Valsartan—coronary artery disease	0.000839	0.00255	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—GATA4—coronary artery disease	0.000835	0.00212	CbGpPWpGaD
Phylloquinone—Dizziness—Olmesartan—coronary artery disease	0.000835	0.00254	CcSEcCtD
Phylloquinone—Hyperhidrosis—Timolol—coronary artery disease	0.000831	0.00253	CcSEcCtD
Phylloquinone—Hypotension—Ramipril—coronary artery disease	0.000822	0.0025	CcSEcCtD
Phylloquinone—Dizziness—Niacin—coronary artery disease	0.000815	0.00248	CcSEcCtD
Phylloquinone—Hypotension—Timolol—coronary artery disease	0.000803	0.00245	CcSEcCtD
Phylloquinone—Dizziness—Pravastatin—coronary artery disease	0.000803	0.00244	CcSEcCtD
Phylloquinone—Anaphylactic shock—Lisinopril—coronary artery disease	0.000798	0.00243	CcSEcCtD
Phylloquinone—Dyspnoea—Ramipril—coronary artery disease	0.000784	0.00239	CcSEcCtD
Phylloquinone—Hypersensitivity—Furosemide—coronary artery disease	0.000783	0.00238	CcSEcCtD
Phylloquinone—Dizziness—Trandolapril—coronary artery disease	0.00078	0.00237	CcSEcCtD
Phylloquinone—Dizziness—Enalapril—coronary artery disease	0.000777	0.00236	CcSEcCtD
Phylloquinone—Hyperhidrosis—Lisinopril—coronary artery disease	0.000771	0.00235	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—MAPK1—coronary artery disease	0.000768	0.00195	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—HSPD1—coronary artery disease	0.000767	0.00195	CbGpPWpGaD
Phylloquinone—Dyspnoea—Timolol—coronary artery disease	0.000767	0.00233	CcSEcCtD
Phylloquinone—Dizziness—Telmisartan—coronary artery disease	0.000766	0.00233	CcSEcCtD
Phylloquinone—BGLAP—FGF signaling pathway—AKT1—coronary artery disease	0.00076	0.00193	CbGpPWpGaD
Phylloquinone—Hypersensitivity—Losartan—coronary artery disease	0.000756	0.0023	CcSEcCtD
Phylloquinone—Hypotension—Lisinopril—coronary artery disease	0.000745	0.00227	CcSEcCtD
Phylloquinone—Dizziness—Captopril—coronary artery disease	0.000745	0.00227	CcSEcCtD
Phylloquinone—Pain—Timolol—coronary artery disease	0.000735	0.00224	CcSEcCtD
Phylloquinone—Dizziness—Perindopril—coronary artery disease	0.000723	0.0022	CcSEcCtD
Phylloquinone—Dyspnoea—Lisinopril—coronary artery disease	0.000711	0.00216	CcSEcCtD
Phylloquinone—Dizziness—Furosemide—coronary artery disease	0.000703	0.00214	CcSEcCtD
Phylloquinone—Pain—Lisinopril—coronary artery disease	0.000682	0.00208	CcSEcCtD
Phylloquinone—Dizziness—Losartan—coronary artery disease	0.000678	0.00206	CcSEcCtD
Phylloquinone—GGCX—Post-translational protein modification—F2—coronary artery disease	0.000659	0.00168	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—IGFBP3—coronary artery disease	0.000648	0.00165	CbGpPWpGaD
Phylloquinone—Hypersensitivity—Ramipril—coronary artery disease	0.000648	0.00197	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—ACTB—coronary artery disease	0.00064	0.00163	CbGpPWpGaD
Phylloquinone—Hypersensitivity—Timolol—coronary artery disease	0.000633	0.00193	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—F7—coronary artery disease	0.000618	0.00157	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—THBS1—coronary artery disease	0.00059	0.0015	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—IL6—coronary artery disease	0.00059	0.0015	CbGpPWpGaD
Phylloquinone—Hypersensitivity—Lisinopril—coronary artery disease	0.000588	0.00179	CcSEcCtD
Phylloquinone—Dizziness—Ramipril—coronary artery disease	0.000582	0.00177	CcSEcCtD
Phylloquinone—Dizziness—Timolol—coronary artery disease	0.000569	0.00173	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—CALR—coronary artery disease	0.000561	0.00143	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—AKT1—coronary artery disease	0.000544	0.00138	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—ACE—coronary artery disease	0.000534	0.00136	CbGpPWpGaD
Phylloquinone—Dizziness—Lisinopril—coronary artery disease	0.000527	0.00161	CcSEcCtD
Phylloquinone—GGCX—Metabolism of proteins—PLAUR—coronary artery disease	0.000479	0.00122	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—PLG—coronary artery disease	0.000469	0.00119	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—MMP1—coronary artery disease	0.000343	0.000872	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—AGT—coronary artery disease	0.000338	0.000861	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—LEP—coronary artery disease	0.000332	0.000844	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—F2—coronary artery disease	0.000313	0.000796	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—POMC—coronary artery disease	0.000285	0.000725	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—CCL2—coronary artery disease	0.000279	0.000709	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—IGF1—coronary artery disease	0.000274	0.000697	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—MMP2—coronary artery disease	0.000265	0.000675	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—CXCL8—coronary artery disease	0.00022	0.000561	CbGpPWpGaD
